CIK 0000744218
- Large accelerated filer
Celldex Therapeutics, Inc.
Sign in to watch- Ticker
- CLDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 133191702
- Phone
- +1 908-200-7500
- Business address
- 53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, 08827
- Former names
- AVANT IMMUNOTHERAPEUTICS INC, T CELL SCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 73 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-06-04 | LIPTON KAREN SHOOS Director | Grant or award | +2,000 | 15,333 | ||
| 2014-06-04 | LIPTON KAREN SHOOS Director | Grant or award · Non-Qualified Stock Option (right to buy) | +2,000 | 2,000 | ||
| 2014-06-04 | PENNER HARRY JR Director | Grant or award | +2,000 | 15,416 | ||
| 2014-06-04 | PENNER HARRY JR Director | Grant or award · Non-Qualified Stock Option (right to buy) | +2,000 | 2,000 | ||
| 2014-06-04 | ELLBERGER LARRY Director | Grant or award | +2,000 | 27,000 | ||
| 2014-06-04 | ELLBERGER LARRY Director | Grant or award · Non-Qualified Stock Option (right to buy) | +2,000 | 2,000 | ||
| 2014-06-04 | CATLIN AVERY W Sr. VP & CFO | Grant or award · Incentive Stock Option | +92,000 | 92,000 | ||
| 2014-06-04 | PEPIN RONALD Sr. VP & CBO | Grant or award · Incentive Stock option | +92,000 | 92,000 | ||
| 2014-06-04 | Davis Thomas Andrew Sr. VP & CMO | Grant or award · Incentive Stock Option | +116,500 | 116,500 | ||
| 2014-06-04 | KELER TIBOR Sr. VP & CSO | Grant or award · Incentive Stock Option | +116,500 | 116,500 | ||
| 2014-06-04 | Marucci Anthony S President & CEO | Grant or award · Incentive Stock Option | +280,000 | 280,000 | ||
| 2013-12-06 | LIPTON KAREN SHOOS Director | Exercise or conversion | +17,728 | $8.16 | $145K | 31,061 |
| 2013-12-06 | LIPTON KAREN SHOOS Director | Sale | −17,728 | $24.50 | $434K | 13,333 |
| 2013-12-06 | LIPTON KAREN SHOOS Director | Exercise or conversion · Non-Qualified Stock Option | −17,728 | 0 | ||
| 2013-12-06 | PENNER HARRY JR Director | Exercise or conversion | +17,728 | $8.16 | $145K | 31,144 |
| 2013-12-06 | PENNER HARRY JR Director | Sale | −17,728 | $24.50 | $434K | 13,416 |
| 2013-12-06 | PENNER HARRY JR Director | Exercise or conversion · Non-Qualified Stock Option | −17,728 | 0 | ||
| 2013-12-06 | ELLBERGER LARRY Director | Exercise or conversion | +17,728 | $8.16 | $145K | 42,728 |
| 2013-12-06 | ELLBERGER LARRY Director | Sale | −17,728 | $24.50 | $434K | 25,000 |
| 2013-12-06 | ELLBERGER LARRY Director | Exercise or conversion · Non-Qualified Stock Option | −17,728 | 0 |
Page 23 of 32 · 629 trades